Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of Muscarinic Acetylcholine Receptor M<sub>3</sub> Activation in Atomistic Detail: A Chemist's Viewpoint.

ChemMedChem·2024
Same author

In Vitro Activities of Dithiocarbamate Derivatives against <i>Echinococcus multilocularis</i> Metacestode Vesicles.

Tropical medicine and infectious disease·2023
Same author

Distortional effects of separate accounting and formula apportionment on factor allocation.

Journal of business economics·2023
Same author

Identification and characterisation of the tegument-expressed aldehyde dehydrogenase SmALDH_312 of Schistosoma mansoni, a target of disulfiram.

European journal of medicinal chemistry·2023
Same author

From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity.

Archiv der Pharmazie·2022
Same author

Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects.

European journal of medicinal chemistry·2022

Related Experiment Video

Updated: May 19, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

The antimalarial pipeline--an update.

Florian C Schrader1, Marlene Barho, Iljana Steiner

  • 1Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 6, D-35032 Marburg, Germany.

International Journal of Medical Microbiology : IJMM
|August 18, 2012
PubMed
Summary

New antimalarial compounds are progressing through development. Advanced stages feature drug combinations, while novel mechanisms of action are found in earlier research for malaria treatment.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Related Experiment Videos

Last Updated: May 19, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

Area of Science:

  • Drug discovery and development
  • Medicinal chemistry
  • Parasitology

Background:

  • Antimalarial drug development is ongoing, with numerous compounds in various research phases.
  • Current advanced-stage antimalarials often involve combinations of existing drugs or known drug classes.

Purpose of the Study:

  • To analyze the landscape of antimalarial compounds in preclinical and clinical development.
  • To identify trends in drug classes and mechanisms of action across different development stages.

Main Methods:

  • Review of preclinical and clinical antimalarial drug development pipelines.
  • Categorization of compounds based on development stage, drug class, and mechanism of action.

Main Results:

  • Predominance of drug combinations and known antimalarial classes in advanced development stages.
  • Emergence of compounds with novel or unknown mechanisms of action in earlier research phases.

Conclusions:

  • The pipeline for antimalarial therapies includes both incremental improvements and potentially transformative new approaches.
  • Further research into novel mechanisms is crucial for addressing drug resistance and improving malaria treatment outcomes.